PMID- 40983680
OWN - NLM
STAT- Publisher
LR  - 20250922
IS  - 2522-5812 (Electronic)
IS  - 2522-5812 (Linking)
DP  - 2025 Sep 22
TI  - The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases.
LID - 10.1038/s42255-025-01365-z [doi]
AB  - Lipid alterations in the brain have been implicated in many neurodegenerative 
      diseases. To facilitate comparative lipidomic research across brain diseases, we 
      establish a data common named the Neurolipid Atlas that we prepopulated with 
      isogenic induced pluripotent stem cell (iPS cell)-derived lipidomics data for 
      different brain diseases. Additionally, the resource contains lipidomics data of 
      human and mouse brain tissue. Leveraging multiple datasets, we demonstrate that 
      iPS cell-derived neurons, microglia and astrocytes exhibit distinct lipid 
      profiles that recapitulate in vivo lipotypes. Notably, the Alzheimer disease (AD) 
      risk gene ApoE4 drives cholesterol ester (CE) accumulation specifically in human 
      astrocytes and we also observe CE accumulation in whole-brain lipidomics from 
      persons with AD. Multiomics interrogation of iPS cell-derived astrocytes revealed 
      that altered cholesterol metabolism has a major role in astrocyte immune pathways 
      such as the immunoproteasome and major histocompatibility complex class I antigen 
      presentation. Our data commons, available online ( https://neurolipidatlas.com/ 
      ), allows for data deposition by the community and provides a user-friendly tool 
      and knowledge base for a better understanding of lipid dyshomeostasis in 
      neurodegenerative diseases.
CI  - © 2025. The Author(s).
FAU - Feringa, Femke M
AU  - Feringa FM
AD  - Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, 
      Amsterdam Neuroscience, Amsterdam, The Netherlands.
FAU - Koppes-den Hertog, Sascha J
AU  - Koppes-den Hertog SJ
AUID- ORCID: 0000-0002-7372-8946
AD  - Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, 
      Amsterdam Neuroscience, Amsterdam, The Netherlands.
AD  - Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical 
      Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
FAU - Wang, Lian Y
AU  - Wang LY
AUID- ORCID: 0009-0006-0509-6680
AD  - Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, 
      The Netherlands.
FAU - Derks, Rico J E
AU  - Derks RJE
AUID- ORCID: 0000-0002-8920-7133
AD  - Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, 
      The Netherlands.
FAU - Kruijff, Iris
AU  - Kruijff I
AD  - Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, 
      Amsterdam Neuroscience, Amsterdam, The Netherlands.
AD  - Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical 
      Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
FAU - Erlebach, Lena
AU  - Erlebach L
AUID- ORCID: 0000-0002-9077-8689
AD  - German Center for Neurodegenerative Diseases (DZNE) Tübingen, Tübingen, Germany.
AD  - Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, 
      University of Tübingen, Tübingen, Germany.
FAU - Heijneman, Jorin
AU  - Heijneman J
AD  - Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, 
      Amsterdam Neuroscience, Amsterdam, The Netherlands.
AD  - Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical 
      Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
FAU - Miramontes, Ricardo
AU  - Miramontes R
AD  - Department of Psychiatry and Human Behavior, University of California, Irvine, 
      Irvine, CA, USA.
AD  - Department of Neurobiology and Behavior, University of California, Irvine, 
      Irvine, CA, USA.
AD  - Institute for Memory Impairments and Neurological Disorders, University of 
      California, Irvine, Irvine, CA, USA.
FAU - Pömpner, Nadine
AU  - Pömpner N
AD  - Leibniz Institute on Aging, Fritz Lipmann Institute, Jena, Germany.
FAU - Blomberg, Niek
AU  - Blomberg N
AD  - Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, 
      The Netherlands.
FAU - Olivier-Jimenez, Damien
AU  - Olivier-Jimenez D
AUID- ORCID: 0000-0002-6363-0857
AD  - Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, 
      The Netherlands.
FAU - Johansen, Lill Eva
AU  - Johansen LE
AUID- ORCID: 0000-0003-2187-6709
AD  - Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, 
      Amsterdam Neuroscience, Amsterdam, The Netherlands.
FAU - Cammack, Alexander J
AU  - Cammack AJ
AD  - Department of Neurodegenerative Disease, Queen Square Institute of Neurology, 
      University College London, London, UK.
AD  - UK Dementia Research Institute, University College London, London, UK.
FAU - Giblin, Ashling
AU  - Giblin A
AD  - UK Dementia Research Institute, University College London, London, UK.
AD  - Institute of Healthy Ageing, University College London, London, UK.
FAU - Toomey, Christina E
AU  - Toomey CE
AUID- ORCID: 0000-0002-5146-3326
AD  - Department of Neurodegenerative Disease, Queen Square Institute of Neurology, 
      University College London, London, UK.
FAU - Rose, Indigo V L
AU  - Rose IVL
AUID- ORCID: 0000-0003-0491-1269
AD  - Institute for Neurodegenerative Diseases, University of California, San 
      Francisco, San Francisco, CA, USA.
AD  - Neuroscience Graduate Program, University of California, San Francisco, San 
      Francisco, CA, USA.
FAU - Yuan, Hebao
AU  - Yuan H
AD  - National Institute of Neurological Disorders and Stroke, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Ward, Michael E
AU  - Ward ME
AD  - National Institute of Neurological Disorders and Stroke, National Institutes of 
      Health, Bethesda, MD, USA.
FAU - Isaacs, Adrian M
AU  - Isaacs AM
AD  - Department of Neurodegenerative Disease, Queen Square Institute of Neurology, 
      University College London, London, UK.
AD  - UK Dementia Research Institute, University College London, London, UK.
FAU - Kampmann, Martin
AU  - Kampmann M
AUID- ORCID: 0000-0002-3819-7019
AD  - Institute for Neurodegenerative Diseases, University of California, San 
      Francisco, San Francisco, CA, USA.
AD  - Department of Biochemistry and Biophysics, University of California, San 
      Francisco, San Francisco, CA, USA.
FAU - Kronenberg-Versteeg, Deborah
AU  - Kronenberg-Versteeg D
AD  - German Center for Neurodegenerative Diseases (DZNE) Tübingen, Tübingen, Germany.
AD  - Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, 
      University of Tübingen, Tübingen, Germany.
FAU - Lashley, Tammaryn
AU  - Lashley T
AD  - Department of Neurodegenerative Disease, Queen Square Institute of Neurology, 
      University College London, London, UK.
FAU - Thompson, Leslie M
AU  - Thompson LM
AD  - Department of Psychiatry and Human Behavior, University of California, Irvine, 
      Irvine, CA, USA.
AD  - Department of Neurobiology and Behavior, University of California, Irvine, 
      Irvine, CA, USA.
AD  - Institute for Memory Impairments and Neurological Disorders, University of 
      California, Irvine, Irvine, CA, USA.
FAU - Ori, Alessandro
AU  - Ori A
AUID- ORCID: 0000-0002-3046-0871
AD  - Leibniz Institute on Aging, Fritz Lipmann Institute, Jena, Germany.
AD  - Genentech, Inc., San Francisco, CA, USA.
FAU - Mohammed, Yassene
AU  - Mohammed Y
AUID- ORCID: 0000-0003-3265-3332
AD  - Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, 
      The Netherlands.
AD  - Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, 
      Canada.
FAU - Giera, Martin
AU  - Giera M
AUID- ORCID: 0000-0003-1684-1894
AD  - Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, 
      The Netherlands. m.a.giera@lumc.nl.
FAU - van der Kant, Rik
AU  - van der Kant R
AUID- ORCID: 0000-0002-7023-0106
AD  - Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, 
      Amsterdam Neuroscience, Amsterdam, The Netherlands. r.h.n.vander.kant@vu.nl.
AD  - Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical 
      Center, Amsterdam Neuroscience, Amsterdam, The Netherlands. 
      r.h.n.vander.kant@vu.nl.
LA  - eng
GR  - 2019-AARG-643165/ALZ/Alzheimer's Association/United States
GR  - ADSF-21-831212-C/ALZ/Alzheimer's Association/United States
GR  - ADSF-21-816750/ALZ/Alzheimer's Association/United States
GR  - WE-03-2017-09P/Alzheimer Nederland (Alzheimer Netherlands)/
GR  - WE.03-2019-13/Alzheimer Nederland (Alzheimer Netherlands)/
GR  - WE.15-2019-16/Alzheimer Nederland (Alzheimer Netherlands)/
GR  - 09150172110086/Nederlandse Organisatie voor Wetenschappelijk Onderzoek 
      (Netherlands Organisation for Scientific Research)/
GR  - 733050515/ZonMw (Netherlands Organisation for Health Research and Development)/
GR  - 435005033/ZonMw (Netherlands Organisation for Health Research and Development)/
GR  - EDUC412812/California Institute for Regenerative Medicine (CIRM)/
GR  - T32NS115706/Foundation for the National Institutes of Health (Foundation for the 
      National Institutes of Health, Inc.)/
GR  - R01 AG062359/AG/NIA NIH HHS/United States
GR  - U01 AG072464/AG/NIA NIH HHS/United States
GR  - P01 NS084974-06A1/Foundation for the National Institutes of Health (Foundation 
      for the National Institutes of Health, Inc.)/
GR  - R35 NS116872/NS/NINDS NIH HHS/United States
PT  - Journal Article
DEP - 20250922
PL  - Germany
TA  - Nat Metab
JT  - Nature metabolism
JID - 101736592
SB  - IM
COIS- Competing interests: R.K. has acted as a consultant for NewAmsterdam Pharma. M.K. 
      is a coscientific founder of Montara Therapeutics, serves on the scientific 
      advisory boards of Engine Biosciences, Casma Therapeutics, Cajal Neuroscience, 
      Alector and Montara Therapeutics and is an advisor to Modulo Bio and Recursion 
      Therapeutics. M.G. is a consultant to Boehringer-Ingelheim Pharma and an inventor 
      of patent application WO2023172132A1. The other authors declare no competing 
      interests.
EDAT- 2025/09/23 03:17
MHDA- 2025/09/23 03:17
CRDT- 2025/09/22 23:20
PHST- 2024/07/29 00:00 [received]
PHST- 2025/08/05 00:00 [accepted]
PHST- 2025/09/23 03:17 [medline]
PHST- 2025/09/23 03:17 [pubmed]
PHST- 2025/09/22 23:20 [entrez]
AID - 10.1038/s42255-025-01365-z [pii]
AID - 10.1038/s42255-025-01365-z [doi]
PST - aheadofprint
SO  - Nat Metab. 2025 Sep 22. doi: 10.1038/s42255-025-01365-z.
